Alex Sapir - President & Chief Executive Officer, Director at Fulcrum Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President & Chief Executive Officer, Director
Stock Symbol
FULC on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Alex Sapir - trading volume in the past year for Fulcrum Therapeutics, Inc.

Holdings reported by Alex Sapir for Fulcrum Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 193K $1.5M $7.76 Jul 3, 2024 Direct
Stock option - Right to Buy 2.28M Jul 3, 2024 Direct Common Stock

Transactions reported by Alex Sapir for Fulcrum Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.